
Sonorous Pharma Private Limited
Founded in 2011 and headquartered in Maharashtra, India.
Founded in 2011 and headquartered in Maharashtra, India.
Aurangabad, Maharashtra, India
+91-XXXXXXXXXX
U85100MH2011PTC219759
219759
Private Limited Indian Non-Government Company
13 Jul 2011
30 Sep 2014
31 Mar 2014
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Monali Santosh ![]() | Director | 13-Jul-2011 | Current |
Santosh Gandhi ![]() | Director | 13-Jul-2011 | Current |
Enhance accessibility to Sonorous Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Sonorous Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Monali Santosh and Santosh Gandhi are mutual person
Santosh Gandhi is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sonorous Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sonorous Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sonorous Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sonorous Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2014 as per latest MCA records.
Sonorous Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2014 with Roc Mumbai.
Monali Gandhi Santosh was appointed as a Director was appointed as a Director on 13 Jul 2011 & has been associated with this company since 13 years 8 months .
Santosh Dagadulal Gandhi was appointed as a Director was appointed as a Director on 13 Jul 2011 & has been associated with this company since 13 years 8 months .
Sonorous Pharma Private Limited was registered on 13 Jul 2011 with Roc Mumbai & aged 13 years 8 months as per MCA records.
Sonorous Pharma Private Limited was incorporated on 13 Jul 2011.
The authorized share capital of Sonorous Pharma Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Sonorous Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Sonorous Pharma Private Limited is 9-1-58 Manjit Nagar, Maheshnagar, Aurangabad, Maharashtra, India, 431001.
The corporate identification number (CIN) of Sonorous Pharma Private Limited is U85100MH2011PTC219759 and the company number is 219759 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Sonorous Pharma Private Limited was filed with the ROC on 31 Mar 2014.
Search company & director profiles for free and gain access to critical business data.